Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma

被引:7
|
作者
Zhou, Xueliang [1 ]
Dou, Mengmeng [2 ]
Liu, Zaoqu [1 ]
Jiao, Dechao [1 ]
Li, Zhaonan [1 ]
Chen, Jianjian [1 ]
Li, Jing [1 ]
Yao, Yuan [1 ]
Li, Lifeng [3 ]
Li, Yahua [1 ]
Han, Xinwei [1 ]
机构
[1] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China
关键词
LONG NONCODING RNA; CANCER; MICRORNAS; IDENTIFICATION; PROLIFERATION; METASTASIS; BIOMARKERS; APOPTOSIS; DIAGNOSIS; PATHWAYS;
D O I
10.1155/2021/5518908
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Hepatocellular carcinoma (HCC) remains an important cause of cancer death. The molecular mechanism of hepatocarcinogenesis and prognostic factors of HCC have not been completely uncovered. Methods. In this study, we screened out differentially expressed lncRNAs (DE lncRNAs), miRNAs (DE miRNAs), and mRNAs (DE mRNAs) by comparing the gene expression of HCC and normal tissue in The Cancer Genome Atlas (TCGA) database. DE mRNAs were used to perform Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Then, the miRNA and lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a competitive endogenous RNA (ceRNA) network by weighted gene coexpression network analysis (WGCNA). Moreover, univariable Cox regression and Kaplan-Meier curve analyses of DE lncRNAs and DE mRNAs were conducted. Finally, the lasso-penalized Cox regression analysis and nomogram model were used to establish a new risk scoring system and predict the prognosis of patients with liver cancer. The expression of survival-related DE lncRNAs was verified by qRT-PCR. Results. A total of 1896 DEmRNAs, 330 DElncRNAs, and 76 DEmiRNAs were identified in HCC and normal tissue samples. Then, the turquoise miRNA and turquoise lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a ceRNA network by WGCNA. In this ceRNA network, there were 566 lncRNA-miRNA-mRNA regulatory pairs, including 30 upregulated lncRNAs, 16 downregulated miRNAs, and 75 upregulated mRNAs. Moreover, we screened out 19 lncRNAs and 14 hub mRNAs related to prognosis from this ceRNA network by univariable Cox regression and Kaplan-Meier curve analyses. Finally, a new risk scoring system was established by selecting the optimal risk lncRNAs from the 19 prognosis-related lncRNAs through lasso-penalized Cox regression analysis. In addition, we established a nomogram model consisting of independent prognostic factors to predict the survival rate of HCC patients. Finally, the correlation between the risk score and immune cell infiltration and gene set enrichment analysis were determined. Conclusions. In conclusion, the results may provide potential biomarkers or therapeutic targets for HCC and the establishment of the new risk scoring system and nomogram model provides the new perspective for predicting the prognosis of HCC.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Identification and Validation of Prognosis-Related Necroptosis Genes for Prognostic Prediction in Hepatocellular Carcinoma
    Gao, Xin
    Huang, Di
    Li, Shu-Guang
    Wang, Wen-Xin
    Sun, Dong-Lei
    Qian, Jia-Ming
    Zhang, Xiao-Lan
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [22] Construction of a new immune-related signature based on three lncRNAs as the factor for prognosis prediction of hepatocellular carcinoma
    Hu, Bo
    Yang, Xiao-Bo
    Sang, Xin-Ting
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (02):
  • [23] Identification of the Potential Prognosis Biomarkers in Hepatocellular Carcinoma: An Analysis Based on WGCNA and PPI
    Huang, Junting
    Zhan, Yating
    Jiang, Lili
    Gao, Yuxiang
    Zhao, Binyu
    Zhang, Yuxiao
    Zhang, Wenjie
    Zheng, Jianjian
    Yu, Jinglu
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 9555 - 9565
  • [24] A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma
    Wang, Shuo
    Bai, Hongyan
    Fei, Sujuan
    Miao, Bei
    BIOCHEMICAL GENETICS, 2024, 62 (03) : 2332 - 2351
  • [25] A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients
    Ye, Dingde
    Liu, Yaping
    Li, Guoqiang
    Sun, Beicheng
    Peng, Jin
    Xu, Qingxiang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
    Zhu, Yuezhi
    Tan, Jen Kit
    Goon, Jo Aan
    BIOLOGY-BASEL, 2023, 12 (08):
  • [27] Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
    Peng, YunZhen
    Wu, GuoJing
    Qiu, Xin
    Luo, Yue
    Zou, YiShu
    Wei, XueYan
    Li, Aimin
    FRONTIERS IN GENETICS, 2022, 13
  • [28] A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients' prognosis
    Lin, Ting
    Gu, Jingxian
    Qu, Kai
    Zhang, Xing
    Ma, Xiaohua
    Miao, Runchen
    Xiang, Xiaohong
    Fu, Yunong
    Niu, Wenquan
    She, Junjun
    Liu, Chang
    AGING-US, 2018, 10 (09): : 2480 - 2497
  • [29] Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma
    Qiongyue Zhang
    Yan Huang
    Yu Xia
    Yumeng Liu
    Jianhe Gan
    Clinical and Experimental Medicine, 2023, 23 : 2051 - 2064
  • [30] Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma
    Zhang, Qiongyue
    Huang, Yan
    Xia, Yu
    Liu, Yumeng
    Gan, Jianhe
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2051 - 2064